Literature DB >> 6090958

Interactions of three inotropic agents, ASL-7022, dobutamine and dopamine, with alpha- and beta-adrenoceptors in vitro.

R R Ruffolo, K Messick, J S Horng.   

Abstract

Three inotropic agents, ASL-7022, dobutamine and dopamine, were evaluated for their alpha- and beta-adrenoceptor mediated effects in vitro in a variety of isolated organs and in radioligand binding studies. All compounds were alpha 1-adrenoceptor agonists in rat and guinea pig aortae, but the rank orders of potency were exactly opposite in these two tissues. Only the rank potency order of dobutamine greater than ASL-7022 greater than dopamine obtained in rat aorta was consistent with the results obtained in radioligand binding studies to alpha 1-adrenoceptors in rat cerebral cortex and to previous results obtained in vivo in the pithed rat. The results obtained in guinea pig aorta did not parallel the radioligand binding studies in rat brain or our previous results in pithed rat, and suggests that species differences exist between postsynaptic vascular alpha 1-adrenoceptors in rat and guinea pig aorta, consistent with previous conclusions. ASL-7022 was found to be a potent alpha 2-adrenoceptor agonist in field-stimulated guinea pig ileum, and was approximately 10-fold more potent than dobutamine in this respect, which was also confirmed by radioligand binding studies to alpha 2-adrenoceptors in rat cerebral cortex. The beta 1-adrenoceptor mediated effects of these compounds were evaluated in guinea pig atria, where the rank order of potency was dobutamine greater than ASL-7022 greater than dopamine. An identical rank order of affinity was established for these compounds by displacement of 3H-dihydroalprenolol from beta 1-adrenoceptors in rat cerebral cortex. The beta 1-adrenoceptor mediated effects of dobutamine and ASL-7022 in guinea pig atria were completely direct in nature and not secondary to the release of endogenous catecholamines. In contrast, a major component of the beta 1-adrenoceptor mediated tachycardia produced by dopamine in guinea pig atria was indirect in nature as evidenced by the marked attenuation in potency that occurred following catecholamine depletion with reserpine. All three compounds elicited beta 2-adrenoceptor mediated inhibition of tone in rat uterus, with the rank order of potency being ASL-7022 greater than dobutamine greater than dopamine. Again, this rank order of beta 2-adrenoceptor potency was also reflected in beta 2-adrenoceptor affinity as assessed by displacement of 3H-dihydroalprenolol from beta 2-adrenoceptors in rat cerebellum. Based on these results, it may be concluded that for alpha-adrenoceptors, dobutamine is a selective alpha 1-adrenoceptor agonist, ASL-7022 is a selective alpha 2-adrenoceptor agonist, and dopamine is a nonselective alpha-adrenoceptor agonist.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6090958     DOI: 10.1007/bf00501436

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  57 in total

1.  Peripheral vascular effects of noradrenaline, isopropylnoradrenaline and dopamine.

Authors:  M J ALLWOOD; A F COBBOLD; J GINSBURG
Journal:  Br Med Bull       Date:  1963-05       Impact factor: 4.291

2.  Heterogeneity of cerebral beta-adrenoceptor binding sites in various vertebrate species.

Authors:  S R Nahorski
Journal:  Eur J Pharmacol       Date:  1978-10-01       Impact factor: 4.432

3.  Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs.

Authors:  S F Vatner; R J McRitchie; E Braunwald
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

4.  Fine structural study of the terminal effecror plexus, neuromuscular and intermuscular relationships in the pulmonary artery.

Authors:  M A Verity; J A Bevan
Journal:  J Anat       Date:  1968-06       Impact factor: 2.610

5.  Differentiation of cardiac and peripheral alpha- and beta-adrenergic responses to dobutamine, etilefrine and xylometazoline in dogs.

Authors:  R Walkenhorst; D Reinhardt; G Arnold
Journal:  Pharmacology       Date:  1981       Impact factor: 2.547

6.  Stereochemical requirements of alpha-2 adrenergic receptors.

Authors:  R R Ruffolo; E L Yaden; J E Waddell
Journal:  J Pharmacol Exp Ther       Date:  1982-09       Impact factor: 4.030

7.  Stimulation by adrenaline and dopamine but not by noradrenaline of myocardial alpha-adrenoceptors mediating positive inotropic effects in human atrial preparations.

Authors:  J Wagner; H J Schümann; A Knorr; N Rohm; J C Reidemeister
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-05       Impact factor: 3.000

8.  Differential effects of the calcium entry blocker D 600 on contractions of rat and guinea-pig aortas, elicited by various alpha-1 adrenoceptor agonists.

Authors:  J J Beckeringh; M J Thoolen; A de Jonge; B Wilffert; P B Timmermans; P A van Zwieten
Journal:  J Pharmacol Exp Ther       Date:  1984-05       Impact factor: 4.030

9.  Reversal by pronethalol of dibenamine blockade: a study on the seminal vesicle of the guinea-pig.

Authors:  S Guimarães
Journal:  Br J Pharmacol       Date:  1969-07       Impact factor: 8.739

10.  An in vitro quantitative analysis of the alpha adrenoceptor partial agonist activity of dobutamine and its relevance to inotropic selectivity.

Authors:  T P Kenakin
Journal:  J Pharmacol Exp Ther       Date:  1981-02       Impact factor: 4.030

View more
  7 in total

1.  Pharmacological characterization of beta-adrenoceptors mediating relaxation of the rat urinary bladder in vitro.

Authors:  P A Longhurst; M Levendusky
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

2.  Relaxant effect of dopamine on the isolated rat uterus.

Authors:  L Estañ; I Martinez-Mir; E Rubio; F J Morales-Olivas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

3.  Presynaptic dopamine DA2-receptors in rabbit jejunal arteries. An electrophysiological study.

Authors:  W Nörenberg; P Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-08       Impact factor: 3.000

4.  Functional and molecular biological evidence for a possible beta3-adrenoceptor in the human detrusor muscle.

Authors:  Y Igawa; Y Yamazaki; H Takeda; K Hayakawa; M Akahane; Y Ajisawa; T Yoneyama; O Nishizawa; K E Andersson
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

5.  Dopaminergic modulation of hippocampal noradrenaline release. Evidence for alpha 2-antagonistic effects of some dopamine receptor agonists and antagonists.

Authors:  R Jackisch; S Moll; T J Feuerstein; G Hertting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-08       Impact factor: 3.000

6.  Interactions of the enantiomers of 3-O-methyldobutamine with alpha- and beta-adrenoceptors in vitro.

Authors:  R R Ruffolo; K Messick; J S Horng
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-05       Impact factor: 3.000

7.  Pharmacological and Genetic Evidence of Dopamine Receptor 3-Mediated Vasoconstriction in Isolated Mouse Aorta.

Authors:  Veronica Zingales; Sebastiano Alfio Torrisi; Gian Marco Leggio; Claudio Bucolo; Filippo Drago; Salvatore Salomone
Journal:  Biomolecules       Date:  2021-03-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.